Literature DB >> 8625151

Pancreas cancer as a second primary malignancy. A population-based study.

A I Neugut1, H Ahsan, E Robinson.   

Abstract

BACKGROUND: The study of second primary malignancies may give clues to the etiology of various cancers. Little is known about risk factors for pancreatic carcinoma; therefore, its occurrence as a second primary malignancy was investigated.
METHODS: Data from the Surveillance, Epidemiology, and End-Results (SEER) program were used for the period from January 1, 1973 through December 31, 1990. Person-years of follow-up for various cancer sites were calculated, excluding the initial 6 months after diagnosis, and were multiplied times the age- and sex-specific incidence rates for pancreas cancer to calculate the expected number of second primary pancreas cancer cases. The observed number of cases was divided by the expected number to estimate the relative risk (RR) of pancreas cancer as a second primary cancer, and 95% confidence limits were calculated.
RESULTS: The risk of second primary cancer was elevated after lung cancer for men (RR 1.3, 95% CI 1.0-1.6) and women (RR 2.5, 95% CI 1.9-3.2). An elevation in risk also was found after head and neck cancer in women (RR 1.8, 95% CI 1.2-2.5) and bladder cancer in women (RR 1.5, 95% CI 1.1-2.0), but not in men. Other significant elevations were found after prostate cancer (RR 1.2, 95% CI 1.1-1.3), and a decreased risk was found after lymphoma in men (RR 0.2, 95% CI 0.0-0.8).
CONCLUSIONS: Second primary pancreas cancer is increased after tobacco-related malignancies, particularly in females, supporting the role of cigarette smoking as a risk factor for pancreas cancer and suggesting a stronger effect of cigarette smoking for women. The elevation in risk after prostate cancer and the decreased risk after lymphoma in males need to be confirmed in other data sets.

Entities:  

Mesh:

Year:  1995        PMID: 8625151     DOI: 10.1002/1097-0142(19950815)76:4<589::aid-cncr2820760408>3.0.co;2-9

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  10 in total

1.  Outcomes in patients with pancreatic cancer as a secondary malignancy: a retrospective single-institution study.

Authors:  Sojun Hoshimoto; Shoichi Hishinuma; Hirofumi Shirakawa; Moriaki Tomikawa; Iwao Ozawa; Yoshiro Ogata
Journal:  Langenbecks Arch Surg       Date:  2019-11-25       Impact factor: 3.445

2.  Incidence of subsequent pancreatic adenocarcinoma in patients with a history of nonpancreatic primary cancers.

Authors:  Sunil Amin; Russell B McBride; Jennie K Kline; Elana B Mitchel; Aimee L Lucas; Alfred I Neugut; Harold Frucht
Journal:  Cancer       Date:  2011-09-01       Impact factor: 6.860

3.  Increased Incidence of Second Primary Pancreatic Cancer in Patients with Prior Colorectal Cancer: A Population-Based US Study.

Authors:  Erik Rahimi; Sachin Batra; Nirav Thosani; Harminder Singh; Sushovan Guha
Journal:  Dig Dis Sci       Date:  2016-04-23       Impact factor: 3.199

Review 4.  Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010.

Authors:  Chakshu Sharma; Karim M Eltawil; Paul D Renfrew; Mark J Walsh; Michele Molinari
Journal:  World J Gastroenterol       Date:  2011-02-21       Impact factor: 5.742

5.  Multiple primary malignant neoplasms in urologic patients.

Authors:  Osman Inci; Esat Kaya; Bulent Alagol; Irfan Huseyin Atakan; Sabahattin Aydin; Hasan Ereselli
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

6.  Two separate synchronous primary genitourinary tumors.

Authors:  Matthew T Smith; Frederick D Taylor; William P Gianakopoulus; Roy R Brown
Journal:  Rev Urol       Date:  2012

7.  Does the occurrence of certain rare cancers indicate an inherited cancer susceptibility?

Authors:  Sara Levene; Gillian Scott; Patricia Price; Jeremy Sanderson; Helen Evans; Claire Taylor; Sylvia Bass; Cathryn Lewis; Shirley Hodgson
Journal:  Fam Cancer       Date:  2003       Impact factor: 2.375

8.  Molecular characterisation of pancreatic ductal adenocarcinoma in patients under 40.

Authors:  F Bergmann; S Aulmann; M N Wente; R Penzel; I Esposito; J Kleeff; H Friess; P Schirmacher
Journal:  J Clin Pathol       Date:  2006-02-23       Impact factor: 3.411

9.  Clinical characteristics of second primary pancreatic cancer.

Authors:  Jung Hyun Jo; In Rae Cho; Jang Han Jung; Hee Seung Lee; Moon Jae Chung; Seungmin Bang; Seung Woo Park; Jae Bock Chung; Si Young Song; Jeong Youp Park
Journal:  PLoS One       Date:  2017-06-26       Impact factor: 3.240

10.  Striking Multiple Primary Tumors that underwent Whipple Procedure due to Periampullary Carcinoma: An Analysis of 21 Cases.

Authors:  Osman N Dilek; Oguzhan Ozsay; Serkan Karaisli; Emine Ö Gür; Ahmet Er; Selda G Haciyanli; Haldun Kar; Fatma H Dilek
Journal:  Euroasian J Hepatogastroenterol       Date:  2018-05-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.